SHARE
Virtual Clinical Trials Market

Virtual Clinical Trials - Global Market Outlook (2019 -2027)

4.3 (85 reviews)
Published: August 2020 ID: SMRC19819
4.3 (85 reviews)
Published: August 2020 ID: SMRC19819

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Virtual Clinical Trials Market is anticipated to grow at a CAGR of 3.9% during 2019-2027. Rising healthcare digitization, need for patient diversity clubbed with enhanced data collection in clinical trials, and adoption of tele health are the major factors propelling the market growth. However, outdated clinical trials are hampering the market growth.

Virtual clinical trials are a relatively new method of collecting safety and efficacy data from human trial participants. These trials take full advantage of the omnipresent technology and online social engagement that are a part of its participants’ lives, by using electronic versions of all trial processes including recruitment, informed consent, patient counselling, and data collection.

Based on the study design, the interventional trials segment is going to have a lucrative growth during the forecast period due to the increasing number of studies to develop new medications for various diseases. Furthermore, the digitalization of various laboratories has fuelled the market growth for this segment.

By geography, Asia Pacific is going to have a lucrative growth during the forecast period due to the rising outsourced research and development activities in this region to deliver advanced healthcare. Furthermore, increasing per capita income and favorable government initiatives coupled with is boosting the market growth across the region.

Some of the key players profiled in the Virtual Clinical Trials Market include Clinical Ink, Covance, CRF Health, ICON plc, LEO Innovation Lab, Medable, Medidata, Oracle, Parexel, PRA Health Sciences, and Science 37.

Implications Covered:
• Cardiovascular Disease
• Oncology

Study Designs Covered:
• Expanded Access Trials
• Interventional Trials
• Observational Trials

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019 2020, 2024, and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary     
      
2 Preface     

 2.1 Abstract    
 2.2 Stake Holders    
 2.3 Research Scope    
 2.4 Research Methodology    
  2.4.1 Data Mining   
  2.4.2 Data Analysis   
  2.4.3 Data Validation   
  2.4.4 Research Approach   
 2.5 Research Sources    
  2.5.1 Primary Research Sources   
  2.5.2 Secondary Research Sources   
  2.5.3 Assumptions   
      
3 Market Trend Analysis     
 3.1 Introduction    
 3.2 Drivers    
 3.3 Restraints    
 3.4 Opportunities    
 3.5 Threats    
 3.6 Emerging Markets    
 3.7 Impact of Covid-19    
      
4 Porters Five Force Analysis     
 4.1 Bargaining power of suppliers    
 4.2 Bargaining power of buyers    
 4.3 Threat of substitutes    
 4.4 Threat of new entrants    
 4.5 Competitive rivalry    
      
5 Global Virtual Clinical Trials Market, By Implication     
 5.1 Introduction    
 5.2 Cardiovascular Disease    
 5.3 Oncology    
      
6 Global Virtual Clinical Trials Market, By Study Design     
 6.1 Introduction    
 6.2 Expanded Access Trials    
 6.3 Interventional Trials    
 6.4 Observational Trials    
      
7 Global Virtual Clinical Trials Market, By Geography     
 7.1 Introduction    
 7.2 North America    
  7.2.1 US   
  7.2.2 Canada   
  7.2.3 Mexico   
 7.3 Europe    
  7.3.1 Germany   
  7.3.2 UK   
  7.3.3 Italy   
  7.3.4 France   
  7.3.5 Spain   
  7.3.6 Rest of Europe   
 7.4 Asia Pacific    
  7.4.1 Japan   
  7.4.2 China   
  7.4.3 India   
  7.4.4 Australia   
  7.4.5 New Zealand   
  7.4.6 South Korea   
  7.4.7 Rest of Asia Pacific   
 7.5 South America    
  7.5.1 Argentina   
  7.5.2 Brazil   
  7.5.3 Chile   
  7.5.4 Rest of South America   
 7.6 Middle East & Africa    
  7.6.1 Saudi Arabia   
  7.6.2 UAE   
  7.6.3 Qatar   
  7.6.4 South Africa   
  7.6.5 Rest of Middle East & Africa   
      
8 Key Developments     
 8.1 Agreements, Partnerships, Collaborations and Joint Ventures    
 8.2 Acquisitions & Mergers    
 8.3 New Product Launch    
 8.4 Expansions    
 8.5 Other Key Strategies    
      
9 Company Profiling     
 9.1 Clinical Ink    
 9.2 Covance    
 9.3 CRF Health    
 9.4 ICON plc    
 9.5 LEO Innovation Lab    
 9.6 Medable    
 9.7 Medidata    
 9.8 Oracle    
 9.9 Parexel    
 9.10 PRA Health Sciences    
 9.11 Science 37    


List of Tables      
1 Global Virtual Clinical Trials Market Outlook, By Region (2018-2027) ($MN)     
2 Global Virtual Clinical Trials Market Outlook, By Implication (2018-2027) ($MN)     
3 Global Virtual Clinical Trials Market Outlook, By Cardiovascular Disease (2018-2027) ($MN)     
4 Global Virtual Clinical Trials Market Outlook, By Oncology (2018-2027) ($MN)     
5 Global Virtual Clinical Trials Market Outlook, By Study Design (2018-2027) ($MN)     
6 Global Virtual Clinical Trials Market Outlook, By Expanded Access Trials (2018-2027) ($MN)     
7 Global Virtual Clinical Trials Market Outlook, By Interventional Trials (2018-2027) ($MN)     
8 Global Virtual Clinical Trials Market Outlook, By Observational Trials (2018-2027) ($MN)     
9 North America Virtual Clinical Trials Market Outlook, By Country (2018-2027) ($MN)     
10 North America Virtual Clinical Trials Market Outlook, By Implication (2018-2027) ($MN)     
11 North America Virtual Clinical Trials Market Outlook, By Cardiovascular Disease (2018-2027) ($MN)     
12 North America Virtual Clinical Trials Market Outlook, By Oncology (2018-2027) ($MN)     
13 North America Virtual Clinical Trials Market Outlook, By Study Design (2018-2027) ($MN)     
14 North America Virtual Clinical Trials Market Outlook, By Expanded Access Trials (2018-2027) ($MN)     
15 North America Virtual Clinical Trials Market Outlook, By Interventional Trials (2018-2027) ($MN)     
16 North America Virtual Clinical Trials Market Outlook, By Observational Trials (2018-2027) ($MN)     
17 Europe Virtual Clinical Trials Market Outlook, By Country (2018-2027) ($MN)     
18 Europe Virtual Clinical Trials Market Outlook, By Implication (2018-2027) ($MN)     
19 Europe Virtual Clinical Trials Market Outlook, By Cardiovascular Disease (2018-2027) ($MN)     
20 Europe Virtual Clinical Trials Market Outlook, By Oncology (2018-2027) ($MN)     
21 Europe Virtual Clinical Trials Market Outlook, By Study Design (2018-2027) ($MN)     
22 Europe Virtual Clinical Trials Market Outlook, By Expanded Access Trials (2018-2027) ($MN)     
23 Europe Virtual Clinical Trials Market Outlook, By Interventional Trials (2018-2027) ($MN)     
24 Europe Virtual Clinical Trials Market Outlook, By Observational Trials (2018-2027) ($MN)     
25 Asia Pacific Virtual Clinical Trials Market Outlook, By Country (2018-2027) ($MN)     
26 Asia Pacific Virtual Clinical Trials Market Outlook, By Implication (2018-2027) ($MN)     
27 Asia Pacific Virtual Clinical Trials Market Outlook, By Cardiovascular Disease (2018-2027) ($MN)     
28 Asia Pacific Virtual Clinical Trials Market Outlook, By Oncology (2018-2027) ($MN)     
29 Asia Pacific Virtual Clinical Trials Market Outlook, By Study Design (2018-2027) ($MN)     
30 Asia Pacific Virtual Clinical Trials Market Outlook, By Expanded Access Trials (2018-2027) ($MN)     
31 Asia Pacific Virtual Clinical Trials Market Outlook, By Interventional Trials (2018-2027) ($MN)     
32 Asia Pacific Virtual Clinical Trials Market Outlook, By Observational Trials (2018-2027) ($MN)     
33 South America Virtual Clinical Trials Market Outlook, By Country (2018-2027) ($MN)     
34 South America Virtual Clinical Trials Market Outlook, By Implication (2018-2027) ($MN)     
35 South America Virtual Clinical Trials Market Outlook, By Cardiovascular Disease (2018-2027) ($MN)     
36 South America Virtual Clinical Trials Market Outlook, By Oncology (2018-2027) ($MN)     
37 South America Virtual Clinical Trials Market Outlook, By Study Design (2018-2027) ($MN)     
38 South America Virtual Clinical Trials Market Outlook, By Expanded Access Trials (2018-2027) ($MN)     
39 South America Virtual Clinical Trials Market Outlook, By Interventional Trials (2018-2027) ($MN)     
40 South America Virtual Clinical Trials Market Outlook, By Observational Trials (2018-2027) ($MN)     
41 Middle East & Africa Virtual Clinical Trials Market Outlook, By Country (2018-2027) ($MN)     
42 Middle East & Africa Virtual Clinical Trials Market Outlook, By Implication (2018-2027) ($MN)     
43 Middle East & Africa Virtual Clinical Trials Market Outlook, By Cardiovascular Disease (2018-2027) ($MN)     
44 Middle East & Africa Virtual Clinical Trials Market Outlook, By Oncology (2018-2027) ($MN)     
45 Middle East & Africa Virtual Clinical Trials Market Outlook, By Study Design (2018-2027) ($MN)     
46 Middle East & Africa Virtual Clinical Trials Market Outlook, By Expanded Access Trials (2018-2027) ($MN)     
47 Middle East & Africa Virtual Clinical Trials Market Outlook, By Interventional Trials (2018-2027) ($MN)     
48 Middle East & Africa Virtual Clinical Trials Market Outlook, By Observational Trials (2018-2027) ($MN) 

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials